|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
75,280,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Xenon Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing therapeutics for patients with neurological disorders. Co.'s product pipeline of neurology-focused therapies focus on epilepsy. Co.'s product candidates include: XEN1101, a Kv7 potassium channel opener for the treatment of epilepsy and potentially other neurological disorders, such as major depressive disorder; and XEN496, a Kv7 potassium channel opener for the treatment of KCNQ2 developmental and epileptic encephalopathy. In addition, Co. has a license and collaboration agreement with Neurocrine Biosciences Inc. to develop NBI-921352, a Nav1.6 sodium channel inhibitor for the treatment of epilepsy.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
22,229 |
48,805 |
236,705 |
576,095 |
Total Sell Value |
$1,027,488 |
$2,098,369 |
$9,481,770 |
$22,449,223 |
Total People Sold |
3 |
4 |
7 |
10 |
Total Sell Transactions |
3 |
6 |
11 |
22 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mortimer Ian |
CFO & COO |
|
2017-08-10 |
4 |
B |
$2.85 |
$14,225 |
D/D |
5,000 |
6,000 |
2.74 |
- |
|
Patou Gary |
Director |
|
2017-08-08 |
4 |
B |
$3.00 |
$15,003 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
Lampert Mark N |
10% Owner |
|
2017-06-27 |
4 |
B |
$4.00 |
$341,844 |
D/D |
85,461 |
297,464 |
2.45 |
- |
|
Lampert Mark N |
10% Owner |
|
2017-06-22 |
4 |
B |
$4.00 |
$33,052 |
D/D |
8,263 |
288,968 |
2.37 |
- |
|
Lampert Mark N |
10% Owner |
|
2017-06-21 |
4 |
B |
$4.00 |
$48,592 |
D/D |
12,148 |
288,114 |
2.37 |
- |
|
Tarnow Michael M |
Director |
|
2017-06-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,028 |
55,167 |
|
- |
|
Tarnow Michael M |
Director |
|
2017-06-19 |
4 |
OE |
$3.51 |
$3,608 |
D/D |
1,028 |
56,195 |
|
- |
|
Lampert Mark N |
10% Owner |
|
2017-06-19 |
4 |
B |
$3.85 |
$13,841 |
D/D |
3,595 |
286,752 |
2.37 |
- |
|
Lampert Mark N |
10% Owner |
|
2017-06-16 |
4 |
B |
$3.85 |
$42,481 |
D/D |
11,034 |
286,395 |
2.37 |
- |
|
Lampert Mark N |
10% Owner |
|
2017-06-15 |
4 |
B |
$3.84 |
$45,196 |
D/D |
11,779 |
285,331 |
2.37 |
- |
|
Lampert Mark N |
10% Owner |
|
2017-06-07 |
4 |
B |
$3.85 |
$800,237 |
D/D |
207,789 |
284,171 |
2.45 |
- |
|
Lampert Mark N |
10% Owner |
|
2017-06-06 |
4 |
B |
$3.75 |
$565,909 |
D/D |
150,909 |
263,577 |
2.45 |
- |
|
Robin Sherrington |
SVP Bus. & Corp. Development |
|
2017-05-12 |
4 |
D |
$4.18 |
$5,622 |
D/D |
(1,345) |
4,734 |
|
- |
|
Robin Sherrington |
SVP Bus. & Corp. Development |
|
2017-05-12 |
4 |
OE |
$3.21 |
$6,603 |
D/D |
2,057 |
6,079 |
|
- |
|
Hayden Michael R |
Director |
|
2017-03-14 |
4 |
OE |
$3.07 |
$40,711 |
I/I |
11,830 |
30,348 |
|
- |
|
Hayden Michael R |
Director |
|
2017-03-14 |
4 |
OE |
$3.67 |
$182,200 |
D/D |
48,868 |
146,187 |
|
- |
|
Tarnow Michael M |
Director |
|
2017-01-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,201 |
55,167 |
|
- |
|
Holler Frank A |
Director |
|
2016-12-15 |
4 |
S |
$7.85 |
$235,500 |
D/D |
(30,000) |
115,869 |
|
- |
|
Tarnow Michael M |
Director |
|
2016-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,202 |
62,368 |
|
- |
|
Tarnow Michael M |
Director |
|
2016-12-12 |
4 |
OE |
$3.21 |
$46,234 |
D/D |
14,403 |
69,570 |
|
- |
|
Patou Gary |
Director |
|
2016-12-06 |
4 |
D |
$7.90 |
$34,784 |
D/D |
(4,403) |
12,028 |
|
- |
|
Patou Gary |
Director |
|
2016-12-06 |
4 |
OE |
$3.21 |
$39,627 |
D/D |
12,345 |
16,431 |
|
- |
|
Azab Mohammad |
Director |
|
2016-12-01 |
4 |
D |
$7.80 |
$34,382 |
D/D |
(4,408) |
12,875 |
|
- |
|
Azab Mohammad |
Director |
|
2016-12-01 |
4 |
OE |
$3.21 |
$39,627 |
D/D |
12,345 |
17,283 |
|
- |
|
Holler Frank A |
Director |
|
2016-08-19 |
4 |
S |
$7.65 |
$91,338 |
D/D |
(11,938) |
145,869 |
|
- |
|
231 Records found
|
|
Page 7 of 10 |
|
|